MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Net Block History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Block | ₹19,004 Cr | ₹4,540 Cr | ₹4,245 Cr | ₹3,583 Cr | ₹1,659 Cr |
What is the latest Net Block ratio of MANKIND PHARMA ?
| Year | Net Block |
|---|---|
| Mar2025 | ₹19,004 Cr |
| Mar2024 | ₹4,540 Cr |
| Mar2023 | ₹4,245 Cr |
| Mar2022 | ₹3,583 Cr |
| Mar2021 | ₹1,659 Cr |
How is Net Block of MANKIND PHARMA Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2025 | ₹19,004 Cr | 318.61 | |
| Mar2024 | ₹4,540 Cr | 6.94 | |
| Mar2023 | ₹4,245 Cr | 18.49 | |
| Mar2022 | ₹3,583 Cr | 115.97 | |
| Mar2021 | ₹1,659 Cr | - | |
Compare Net Block of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹88,960.5 Cr | 5.8% | 1.9% | -13.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 5.8% |
1.9% |
-13.1% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses